Summary

EPA’s revised timeline gives electronic chemical manufacturers and importers more preparation time, but it does not remove the need to reconstruct PFAS-related manufacturing and import records covering 2011 through 2022.

The News in Brief

EPA signed its final timing action on April 8, 2026, announced it on April 9, and published it in the Federal Register on April 13. The amendment became effective on the publication date.

Under the April 2026 final timing rule, the TSCA Section 8(a)(7) submission period will begin on the earlier of:

• January 31, 2027; or
• 60 days after the effective date of EPA’s forthcoming final rule addressing the substantive reporting requirements.

The April action changes only the start of the submission period. It does not finalize the proposed exemptions, establish the final reporting deadline or introduce a new restriction on fluorinated electronic chemicals.

As of July 27, 2026, the exemptions covering imported articles, certain byproducts, impurities, R&D chemicals, non-isolated intermediates and PFAS present in mixtures or articles at concentrations below 0.1% remain proposals. They appear in EPA’s November 2025 proposed revisions, not in a completed final rule.

Regulatory Timeline

EPA retained the currently codified six-month submission period, with an additional six months for a qualifying small manufacturer whose reporting obligations arise exclusively from article imports. The agency has stated that the duration and final deadline may be addressed in the forthcoming substantive action.

The rule remains retrospective. The practical question is not only whether a company purchases a fluorinated material today. It is whether a U.S. legal entity manufactured or imported a covered PFAS for a commercial purpose during any year from 2011 through 2022.

Who Should Review Historical Records First?

Record reconstruction may be more difficult for companies with unclear importer roles, confidential formulations or multiple historical product versions than for companies with larger but well-documented volumes.

The review should begin with the legal entity and transaction structure rather than a general search for the word “PFAS.”

A business unit described internally as a distributor may still have acted as the importer of record for particular shipments. The same product grade may also have been purchased domestically in one year and imported directly in another.

The review therefore needs to follow the U.S. legal entity, shipment and supply route—not only the commercial product name.

Historical Supplier and Formulation Versions

A current supplier declaration cannot automatically establish the composition of a material supplied in 2013, 2017 or 2021.

Electronic chemical products may be reformulated while retaining the same commercial function, trade name or customer-facing grade code. A fluorinated surfactant, leveling additive, processing aid or carrier component may change without creating a completely new product identity.

These version-control issues are especially relevant when OLED materials and intermediates move from laboratory evaluation to pilot production and commercial supply under increasingly controlled purity, batch-consistency and documentation requirements.

Each historical purchase should be connected to:

• The legal manufacturer and distributor used in that year;
• The product name and grade code shown on the transaction;
• The applicable specification or formulation revision;
• The effective period covered by the PFAS declaration;
• Any change notice affecting fluorinated components;
• The U.S. entity responsible for importation.

A declaration issued in 2026 may accurately describe the current formulation while offering no evidence about earlier versions.

The wording of the declaration also matters. “No intentionally added PFAS” does not necessarily establish that no reportable substance was present as an impurity, byproduct, processing aid or confidential component. “Compliant with current PFAS restrictions” answers a different question from retrospective TSCA reporting.

The strongest response identifies the product grade, legal manufacturer, composition basis and years covered. A yes-or-no statement without an effective period may be accurate but still unusable for historical reconstruction.

Why the SDS and COA Cannot Answer the Whole Question

A PFAS substance not appearing on the Safety Data Sheet is not proof that the material contained no reportable PFAS.

SDS disclosure is shaped by hazard communication, classification and disclosure requirements. TSCA Section 8(a)(7) is an information-reporting rule with a different purpose and scope.

A Certificate of Analysis is narrower. It confirms selected batch-release parameters, which may include purity, water, acidity, trace metals, particle level or color. It does not normally disclose the complete formulation, every processing aid or all trace components.

The records perform different functions:

• SDS: supports product identity and disclosed hazardous-ingredient review;
• COA: confirms the supplied batch and tested release parameters;
• Specification: defines controlled quality requirements;
• PFAS declaration: states composition status within a defined product and time scope;
• Import record: identifies the shipment, importer and transaction route.

The same document-boundary problem appears when buyers interpret analytical results. For example, an HPLC area percentage cannot automatically be treated as an assay result. The related article on why HPLC area purity cannot be directly equated with assay explains how the reported parameter, analytical method and purchasing specification must be matched before a COA conclusion is accepted.

A defensible historical conclusion usually requires transaction evidence and composition evidence to be matched to the same grade, legal entity and reporting year.

Which Electronic Chemical Records Are Most Exposed?

Proprietary Additives and Confidential Mixtures

Documentation gaps are more likely where a material was recorded under a generic description such as:

• Fluorinated surfactant;
• Surface modifier;
• Wetting or leveling additive;
• Specialty processing aid;
• Proprietary coating additive;
• Fluoropolymer dispersion.

The absence of a CAS number from the buyer’s material master does not close the review. The supplier may possess composition information while treating the precise identity as confidential business information.

The useful question is not simply:

Does this product contain PFAS?

It is:

Which grades, formulation versions and supply years does the supplier’s answer cover?

Where the supplier cannot disclose the identity directly to the customer, the parties may need to determine whether confidential information can be provided through the applicable EPA reporting process.

Import and Annual-Volume Data

The rule calls for information by reporting year. A cumulative purchase total for the entire lookback period is unlikely to resolve annual reporting fields.

Useful records may include:

• Customs and importer-of-record data;
• Purchase orders and goods receipts;
• Toll-manufacturing agreements;
• Intercompany inventory transfers;
• Product and grade master data;
• Batch or production histories;
• Archived sample and trial orders.

The reconciliation should separate the U.S. legal entity, calendar year, product grade, physical form and transaction role.

One procurement error is to treat supplier sales volume as equivalent to the buyer’s import volume. The supplier may have shipped through a U.S. distributor, transferred stock between affiliates or changed the named importer. The material can remain the same while the reporting position changes.

R&D Samples and Test-Marketing Materials

Small laboratory orders can be missed because they may never enter the approved commercial material system.

A scientist may purchase a sample against a project code, receive it through an overseas technical contact or use a temporary grade identifier that disappears when the project ends. The material may later be replaced before commercial launch, leaving no trace in the final bill of materials.

Under the currently codified framework, manufacturing or importing for an immediate or eventual commercial advantage can include certain R&D and test-marketing activities. EPA has proposed an R&D exemption, but it has not yet become a final exclusion.

The review should establish:

• Whether the material entered the United States;
• Which entity acted as importer;
• Which project received it;
• The quantity imported in each relevant year;
• Whether the order can be connected to a substance or mixture identity.

A sample that failed technical qualification may still be relevant to historical import reconstruction.

Sample, Pilot and Commercial Supply Records Present Different Risks

A declaration obtained during laboratory evaluation should not automatically be assumed to cover the later production grade.

In some electronic chemical qualification programs, sample, pilot and commercial supply may come from different manufacturing sites or distribution routes.

A successful technical qualification does not prove regulatory continuity. Coating behavior, purity, process stability or electrical performance may remain within specification even when a low-level additive or processing aid changes.

Quality consistency and historical composition traceability are related controls, but they do not answer the same question.

What Buyers, Quality Teams and R&D Groups Should Recheck Now

A broad PFAS-free questionnaire sent to every supplier often produces statements that are too general to support a historical conclusion.

A more useful request asks:

1. Which product grades and supply years does the declaration cover?
2. Did the formulation, legal manufacturer or manufacturing site change between 2011 and 2022?
3. Was the U.S. transaction a domestic purchase, bulk import, mixture import or article import?
4. Can confidential chemical identity or composition information be provided through an appropriate EPA mechanism if reporting is required?

Procurement should identify the legal manufacturer, distributor and importer of record. Quality teams should compare supplier declarations with specification revisions, change notices and retained batch records. R&D groups should locate sample and pilot orders that never entered the approved material master.

The final internal record should preserve four different evidence positions:

• PFAS identified: historical activity and substance information are available;
• No PFAS identified for the stated grade and period: the supporting evidence has a defined scope;
• Potentially dependent on a proposed exemption: classification must wait for the substantive final rule;
• Historical evidence unresolved: composition, reporting year or importer status cannot yet be confirmed.

This avoids converting missing information into an unsupported compliance conclusion.

What Will Not Change Immediately

The revised schedule does not create a new PFAS ban for electronic chemicals.

It does not require every company to replace fluorinated materials, reformulate existing products or suspend imports. It also does not establish a universal testing obligation for every archived grade. The April 2026 action changes the start of an information-reporting period.

The timing amendment does not finalize the proposed exemptions. Imported articles, R&D materials, impurities, byproducts, non-isolated intermediates and low-concentration mixtures should not be removed from an internal review solely because EPA has proposed excluding them.

Historical gaps do not automatically require laboratory analysis. A discontinued material may no longer have retained samples, and a new analytical result cannot independently establish who imported a historical shipment, how much was imported or which formulation was supplied years earlier.

The practical task remains evidence reconstruction using company records and information reasonably available through employees, suppliers and business contacts.

Industry Judgment: The Main Risk Is Misclassifying the Evidence

The unresolved exemptions may substantially change which activities ultimately require reporting. They should not become the only focus of preparation.

The main operational risk is treating different types of evidence as though they support the same conclusion. A material-composition statement, an SDS disclosure and an importer-of-record entry answer separate questions. None should be used outside its documented scope.

The delay changes the sensible order of work. Companies do not need to complete final submission forms before EPA resolves the substantive revisions. They do need to identify evidence gaps, preserve historical records and distinguish confirmed positions from conclusions that depend on a proposed exemption.

This distinction matters to each target reader:

• Procurement must connect purchasing records to the actual importing entity;
• Quality must connect declarations to product and formulation versions;
• R&D must connect samples and trial lots to historical shipments;
• Compliance must avoid treating proposed exclusions as final law.

Documentation practices may begin changing before reporting opens. Buyers may request declaration effective dates, formulation-change notification and clearer distinctions between intentional ingredients, impurities and confidential components.

Those practices are not required by the April timing action. They address the traceability problems exposed by the retrospective review.

Short-Term and Mid-Term Implications

What Remains Uncertain?

EPA still needs to complete its substantive action on the November 2025 proposal.

That action will determine whether the proposed exemptions are adopted, revised or rejected. It may also change the length and closing date of the submission period.

Companies should watch for:

• Publication of the substantive final rule;
• Confirmation of the final exemptions;
• The definitive submission opening date;
• Any change to the six- or 12-month duration;
• Revised EPA instructions and FAQs;
• Availability of the CDX reporting application.

The final reporting population cannot be determined from the April timing amendment alone. Materials that may qualify for a future exemption should remain identifiable in the evidence set until the substantive rule is published.

For electronic chemical inquiries involving PFAS documentation, buyers can submit a product inquiry to ChemicalCell with the product grade, relevant supply period, intended U.S. importer and required declaration scope so that available raw-material documentation can be matched to the requested transaction.